Clinical Effect of Combined Treatment with Recombinant Human TypeⅡTumor Necrosis Factor Receptor-Antibody Fusion Protein on Osteoporosis Secondary to Active Ankylosing Spondylitis

BAI Yun-jing; WANG Xiao-ying; JIN Xiao-rong; ZHANG Yi-fan; XU Xiao-hua; WU fan; JIANG De-xun

doi:10.3969/j.issn.1002-3429.2020.11.009

Home>Articles>Clinical Effect of Combined Treatment with Recombinant Human TypeⅡTumor Necrosis Factor Receptor-Antibody Fusion Protein on Osteoporosis Secondary to Active Ankylosing Spondylitis

DOI: 10.3969/j.issn.1002-3429.2020.11.009

Clinical Effect of Combined Treatment with Recombinant Human TypeⅡTumor Necrosis Factor Receptor-Antibody Fusion Protein on Osteoporosis Secondary to Active Ankylosing Spondylitis

BAI Yun-jing

WANG Xiao-ying

JIN Xiao-rong

ZHANG Yi-fan

XU Xiao-hua

WU fan

JIANG De-xun

Machine-generated Keywords：

Publication Date：2020-11-22

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 41-46 )

Clinical Misdiagnosis & Mistherapy

ISTIC

ISSN：1002-3429

Year, Vol.(Issue)：2020,33(11)